` ICE (Medinice SA) vs WIG20 Comparison - Alpha Spread

M
ICE
vs
W
WIG20

Over the past 12 months, ICE has significantly outperformed WIG20, delivering a return of +106% compared to the WIG20's +42% growth.

Stocks Performance
ICE vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ICE vs WIG20

Performance Gap Between ICE and WIG20
HIDDEN
Show

Performance By Year
ICE vs WIG20

Loading
ICE
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Medinice SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Medinice SA
Glance View

Market Cap
119.1m PLN
Industry
Health Care

Medinice SA is engaged in providing cardiological & cardiosurgical devices and solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2018-09-25. The firm specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The firm cooperates with research centers in Poland and Europe. The company strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.

ICE Intrinsic Value
HIDDEN
Show
Back to Top